[en] The European recommendations for the management of infective endocarditis have been updated in 2015. The therapeutic modalities depend on both a better prevention in high-risk population, a faster diagnosis through new approaches in medical imaging, and interdisciplinary collaboration by an " endocarditis team. " Treatment involves antimicrobial therapy which can be complex, initially empirical and then targeted, depending on local infectious epidemiology, and whether the infringement affects a native or a prosthetic valve. The surgical indications are identified in the individual patient, based on the response to medical therapy, on complications (heart failure, uncontrolled infection and prevention of embolic events) the germ, the type of valve involved, and of course an integration with the patient's comorbidities.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
MARCHETTA, Stella ; Centre Hospitalier Universitaire de Liège - CHU > Service de cardiologie
Iovino, A.; Service de Cardiologie, Département de Medicine, Heart Valve Clinic, CHU Sart-Tilman, Liège, Belgium
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Imagerie cardiaque fonctionnelle par échographie
Pierard, Luc ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Language :
French
Title :
Actualités thérapeutiques dans l'endocardite infectieuse http://www.revmed.ch/contentrevmed/download/180856/1775148
Habib G, Lancellotti P, Antunes MJ, et al. ESC Guidelines for the management of infective endocarditis The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) 2015. Eur Heart J 2015;36:3075-128.
Duval X, Leport C. Prophylaxis of infective endocarditis: Current tendencies, continuing controversies. Lancet Infect Dis 2008;8:225-32.
Fagman E, Perrotta S, Bech-Hanssen O, et al. EC G-gated computed tomography: A new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol 2012;22:2407-14.
Snygg-Martin U, Gustafsson L, Rosengren L, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: A prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008;47:23-30.
Cosgrove SE, Vigliani GA, Fowler VG, et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009;48:713-21.
Dahl A, Rasmussen RV, Bundgaard H, et al. Enterococcus faecalis infective endocarditis: A pilot study of the relationship between duration of gentamicin treatment and outcome. Circulation 2013;127:1810-7.
Miro JM, Garcia-de-la-Maria C, Armero Y, et al. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009;53:4172-7.
Dhand A, Bayer AS, Pogliano J, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: Role of enhanced daptomycin binding. Clin Infect Dis 2011;53:158-63.
Miro JM, Entenza JM, del Rio A, et al. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2012;56: 4511-5.
Lee A, Mirrett S, Reller LB, et al. Detection of bloodstream infections in adults: How many blood cultures are needed? J Clin Microbiol 2007;45:3546-8.
P aul M, Zemer-Wassercug N, Talker O, et al. Are all beta-lactams similarly effective in the treatment of methicillinsensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 2011;17:1581-6.
Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: Lessons from the Euro heart survey. Heart 2005;91:571-5.
Nadji G, Rusinaru D, Remadi JP, et al. Heart failure in leftsided native valve infective endocarditis: Characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail 2009;11: 668-75.
Kiefer T, Park L, Tribouilloy C, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 2011;306:2239-47.
Ellis ME, Al Abdely H, Sandridge A, et al. Fungal endocarditis: Evidence in the world literature, 1965-1995. Clin Infect Dis 2001;32:50-62.
Chirouze C, Cabell CH, Fowler VG, et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis 2004;38:1323-7.
Rohmann S, Erbel R, Darius H, et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 1991;4:465-74.
Shiue AB, Stancoven AB, Purcell JB, et al. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis. Am J Cardiol 2010;106:1011-5.
Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: A propensity analysis. Eur Heart J 2011;32:2027-33.
De Kerchove L, Price J, Tamer S, et al. Extending the scope of mitral valve repair in active endocarditis. J Thorac Cardiovasc Surg 2012;143(Suppl.):S91-5.
Mayer K, Aicher D, Feldner S, et al. Repair versus replacement of the aortic valve in active infective endocarditis. Eur J Cardiothorac Surg 2012;42:122-7.
Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335:407-16.
Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: Current approach and therapeutic options. Prog Cardiovasc Dis 2008;50:274-81.
Lopez J, Sevilla T, Vilacosta I, et al. Clinical significance of congestive heart failure in prosthetic valve endocarditis. A multicenter study with 257 patients. Rev Esp Cardiol (Engl Ed) 2013;66:384-90.
Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: A population-based study. Arch Intern Med 2007;167:669-75.
Villamil CI, Rodriguez FM, Van den Eynde CA, et al. Permanent transvenous pacemaker infections: An analysis of 59 cases. Eur J Intern Med 2007;18:484-8.
Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-65.
Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49:1851-9.
Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: Review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000;30: 374-9.
